Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Sales: 2020-2024

Historic Return on Sales for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to 0.26%.

  • Journey Medical's Return on Sales rose 17.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 17.00%. This contributed to the annual value of 0.26% for FY2024, which is 21.00% down from last year.
  • Latest data reveals that Journey Medical reported Return on Sales of 0.26% as of FY2024, which was down 437.14% from 0.05% recorded in FY2023.
  • In the past 5 years, Journey Medical's Return on Sales registered a high of 0.11% during FY2020, and its lowest value of 0.70% during FY2021.
  • For the 3-year period, Journey Medical's Return on Sales averaged around 0.24%, with its median value being 0.26% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by 81bps in 2021, then surged by 35bps in 2023.
  • Journey Medical's Return on Sales (MRY) stood at 0.11% in 2020, then crashed by 727bps to 0.70% in 2021, then skyrocketed by 42bps to 0.40% in 2022, then surged by 88bps to 0.05% in 2023, then plummeted by 437bps to 0.26% in 2024.
  • Its Return on Sales was 0.26% in FY2024, compared to 0.05% in FY2023 and 0.40% in FY2022.